findmyKOL

Daniel Claassen, MD

Enriched profile

Professor of Neurology and Professor of Psychology & Human Development; Chief of the Behavioral and Cognitive Neurology Division · Vanderbilt University Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Nashville, TN · Southeast · United StatesSpecialtyNeurologyFocusParkinson's Disease Mechanisms and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2013–2026

Daniel Claassen is Professor of Neurology and Professor of Psychology & Human Development; Chief of the Behavioral and Cognitive Neurology Division at Vanderbilt University Medical Center. OpenAlex indexes 349 publications with 8,118 citations (h-index 45); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 18 Oct 2026

Overview

Updated 18 Oct 2026

Daniel Claassen, M.D., is Professor of Neurology and Professor of Psychology & Human Development at Vanderbilt University Medical Center. The public record shows 349 publications with 8,118 citations (h-index 45), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Genetic Neurodegenerative Diseases. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 15 companies, 7 NIH-funded awards (2013–2026).

  • Most recent indexed publication: 2026 · Annals of clinical and translational neurology
  • Top research focus: Parkinson's Disease Mechanisms and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 15 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Parkinson's Disease2 trialsAlzheimer's / Dementia

Research focus

OpenAlex concept fingerprint
Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsGenetic Neurodegenerative DiseasesDementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications

Drugs & molecules

across trials, industry payments and publications
Austedogeneric · DeutetrabenazineClinical trials—Industry payments74Publications4Ingrezzageneric · ValbenazineClinical trials—Industry payments51Publications1Nuplazidgeneric · PimavanserinClinical trials—Industry payments20Publications—Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments9Publications—Ongentysgeneric · OpicaponeClinical trials—Industry payments9Publications—Ajovygeneric · FremanezumabClinical trials—Industry payments5Publications—Firdapsegeneric · AmifampridineClinical trials—Industry payments2Publications—Nourianzgeneric · IstradefyllineClinical trials—Industry payments2Publications—Northerageneric · DroxidopaClinical trials—Industry payments1Publications—Vyalevgeneric · Carbidopa / levodopaClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments84Neurocrine BioSciences, Inc.Clinical trials—Industry payments69Abbvie Inc.Clinical trials—Industry payments27PTC Therapeutics, Inc.Clinical trials—Industry payments22ACADIA Pharmaceuticals IncClinical trials—Industry payments20Spark Therapeutics, Inc.Clinical trials—Industry payments10Novartis Pharmaceuticals CorporationClinical trials—Industry payments6Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments3Catalyst Pharmaceuticals, Inc.Clinical trials—Industry payments2F. Hoffmann-La Roche AGClinical trials—Industry payments2Kyowa Kirin, Inc.Clinical trials—Industry payments2Sage Therapeutics, Inc.Clinical trials—Industry payments2Vanderbilt University Medical CenterClinical trials2Industry payments—Lundbeck LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
349publications

Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.

8,118citations

Total citations across indexed works.

45h-index

Hirsch index (OpenAlex). i10-index 122.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
15companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
7NIH grants · 2013–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    100%
    Other nervous system drugs100%
    Austedo Xr61%Austedo39%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

7 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Manus Joseph Donahue64Kilian Hett43Paula Trujillo41Hakmook Kang37Ciaran Michael Considine35Colin D. McKnight33Katherine E. McDonell30Alexander K. Song29David A. Stamler26Scott A. Wylie23Jarrod J. Eisma22Erin E. Furr-Stimming22Nelleke Corine van Wouwe22Jason Elenberger21David Harold Zald20David Alan Isaacs19Benoît M. Dawant17Adam J. Stark17Bennett A. Landman16Anna C. Pfalzer16Kristen E. Kanoff15Kaitlyn R. Hay15Samuel Frank15Victor Sung15Elise Kayson15Ya‐Chen Lin14Kalen J. Petersen14Bruce E. Compas14Wery P. M. van den Wildenberg13Dietrich Haubenberger13Megan A. Aumann12Melanie Leguizamon12Abagail E. Ciriegio11Peter Hedera11Kelly Haker Watson11Joseph Samir Neimat11Yan Yan11Italo Biaggioni10Cyndya A. Shibao10Lisa M. Hale10

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/daniel-claassen-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    hopeforthecaregiver.libsyn.com/parkinsons-psychosis-daniel-classen-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeforthecaregiver.libsyn.com ↗
  • Other

    huntingtonsg.podbean.com/e/episode-1-dr-daniel-claassen

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →huntingtonsg.podbean.com ↗
  • Other

    vumc.org/neurology/person/daniel-claassen-md-ms

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vumc.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.